These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A2A receptor antagonists do not induce dyskinesias in drug-naive or L-dopa sensitized rats. Jones N; Bleickardt C; Mullins D; Parker E; Hodgson R Brain Res Bull; 2013 Sep; 98():163-9. PubMed ID: 23838432 [TBL] [Abstract][Full Text] [Related]
24. Serotonin-dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesias. Carta M; Carlsson T; Muñoz A; Kirik D; Björklund A Prog Brain Res; 2008; 172():465-78. PubMed ID: 18772046 [TBL] [Abstract][Full Text] [Related]
25. The neuropharmacology of tardive dyskinesia, spontaneous dyskinesia, and other dystonias. Stahl SM; Davis KL; Berger PA J Clin Psychopharmacol; 1982 Oct; 2(5):321-8. PubMed ID: 6127351 [TBL] [Abstract][Full Text] [Related]
26. Chronic high dose L-dopa treatment does not alter the levels of dopamine D-1, D-2 or D-3 receptor in the striatum of normal monkeys: an autoradiographic study. Zeng BY; Pearce RK; MacKenzie GM; Jenner P J Neural Transm (Vienna); 2001; 108(8-9):925-41. PubMed ID: 11716146 [TBL] [Abstract][Full Text] [Related]
28. [Pharmacological mechanisms of the treatment of dyskinesias in Parkinson disease]. Jiménez-Jiménez FJ; Molina JA; Ortí-Pareja M Rev Neurol; 1999 May 1-15; 28(9):889-98. PubMed ID: 10390756 [TBL] [Abstract][Full Text] [Related]
34. Levodopa-induced dyskinesia in Parkinson's disease. Brotchie JM; Lee J; Venderova K J Neural Transm (Vienna); 2005 Mar; 112(3):359-91. PubMed ID: 15614429 [TBL] [Abstract][Full Text] [Related]
35. Intranigral administration of substance P receptor antagonist attenuated levodopa-induced dyskinesia in a rat model of Parkinson's disease. Yang X; Zhao H; Shi H; Wang X; Zhang S; Zhang Z; Zu J; Zhang W; Shen X; Cui G; Hua F Exp Neurol; 2015 Sep; 271():168-74. PubMed ID: 26001615 [TBL] [Abstract][Full Text] [Related]
36. Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's disease. Zesiewicz TA; Sullivan KL; Maldonado JL; Tatum WO; Hauser RA Mov Disord; 2005 Sep; 20(9):1205-9. PubMed ID: 15954135 [TBL] [Abstract][Full Text] [Related]